Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors
13 Visninger
• 07/13/23
0
0
Indlejre
administrator
Abonnenter
James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors
For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer